Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/4/2025

Amoxicillin for Pediatric Pneumonia

Age-Specific Recommendations

  • The American Academy of Pediatrics recommends amoxicillin as the first-line antibiotic for treating community-acquired pneumonia in children, including previously healthy, appropriately immunized infants, preschool children, school-aged children, and adolescents with mild to moderate bacterial pneumonia 1, 2, 3, 4
  • Amoxicillin is the first choice for oral antibiotic therapy in infants and preschool children because it is effective against the majority of pathogens causing community-acquired pneumonia in this age group, particularly Streptococcus pneumoniae, is well tolerated, and inexpensive 5
  • The Infectious Diseases Society of America recommends a dose of 90 mg/kg/day divided into 2 doses for outpatient management of community-acquired pneumonia in infants and preschool children 6

Important Clinical Caveats

  • The American Academy of Pediatrics suggests that antimicrobial therapy is not routinely required for preschool-aged children with community-acquired pneumonia because viral pathogens are responsible for the great majority of clinical disease 1, 2, 3, 4
  • Young children presenting with mild symptoms of lower respiratory tract infection need not be treated with antibiotics, according to the British Thoracic Society 5

Route of Administration

  • Oral amoxicillin is safe and effective for children presenting with community-acquired pneumonia, as stated by the British Thoracic Society 5
  • Intravenous antibiotics should be used when the child is unable to absorb oral antibiotics or presents with severe signs and symptoms, according to the British Thoracic Society 5

Hospitalized Patients

  • The Infectious Diseases Society of America recommends ampicillin or penicillin G for fully immunized infants or school-aged children admitted to a hospital ward when local epidemiology documents lack of substantial high-level penicillin resistance 1, 2, 3, 4
  • Third-generation parenteral cephalosporins, such as ceftriaxone or cefotaxime, should be prescribed for hospitalized infants and children who are not fully immunized, in regions with high-level penicillin resistance, or for life-threatening infections, including empyema, as recommended by the Infectious Diseases Society of America 1, 2, 4

Alternatives to Amoxicillin

  • Alternative agents, including co-amoxiclav, cefaclor, erythromycin, clarithromycin, and azithromycin, can be used for patients with penicillin allergy, according to the British Thoracic Society 5
  • Macrolide antibiotics should be prescribed for children with findings compatible with atypical pathogens, as recommended by the Infectious Diseases Society of America 1, 2, 3, 4

Monitoring and Follow-Up

  • Children cared for at home should be reviewed if deteriorating or if not improving after 48 hours on treatment, according to the British Thoracic Society 5